Synairgen doses first patients with COVID-19 drug

J&J and US government invest $1 billion in COVID-19 vaccine

Johnson & Johnson has announced plans to team up with the US government to invest more than  $1 billion in a new vaccine against COVID-19, aiming to begin clinical trials by September.<

Sanofi begins trial of Kevzara against COVID-19 complication...

Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe disease.

Equal coronavirus vaccine access a “real issue”

Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided by expedited regulatory processes, questions still remain over how count

Pharma companies that don’t change during COVID-19 will be ‘...

Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they were working before the COVID-19 crisis could soon find themselves irrelevant on

FDA approves AZ Imfinzi in new lung cancer use

AstraZeneca has reported a double win after the FDA approved its Imfinzi for a form of lung cancer, and it stopped a trial of its Farxiga after showing “overwhelming efficacy” in chronic ki